New Delhi: Hours after the launch of ‘Coronil and Swasari’, an Ayurvedic medicine by Patanjali Ayurveda, which claimed to cure COVID – 19 infection, with a “100 per cent” recovery rate, the AYUSH Ministry has asked Patanjali to stop advertising its claims.
“Ministry of AYUSH has taken cognizance of the news being recently flashed in the media about Ayurvedic medicines developed for treatment of COVID-19 by Patanjali Ayurveda Ltd. Haridwar (Uttarakhand). Facts of the claim and details of the stated scientific study are not known to the Ministry,” the AYUSH Ministry said in a press release.
Considering that advertisement of such drugs was regulated under the provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, the Ministry has asked Patanjali to provide additional details of the drug, the research study about it, and to stop advertising its claims until the issue is evaluated.
“The concerned Ayurvedic drug manufacturing company has been informed that such advertisements of drugs including Ayurvedic medicines are regulated under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder and the directives issued by the Central Government in the wake of COVID outbreak.
Ministry had also issued a Gazette Notification No. L.11011/8/2020/AS dated 21st April, 2020 stating the requirements and the manner the research studies on COVID-19 with Ayush interventions/medicines should be undertaken,” the release said.